Références
Lane DA, Lip GY, Beevers DG (2009) Improving survival of malignant hypertension patients over 40 years. Am J Hypertens 22:1199–204
Ahmed ME, Walker JM, Beevers DG, Beevers M (1986) Lack of difference between malignant and accelerated hypertension. Br Med J (Clin Res Ed) 292:235–7
2013) ESH/ESC Task force for the management of arterial hypertension. J Hypertens 31:1925–38
Rubin S, Lacraz A, Galantine V, Gosse P (2014) Malignant hypertension and interferon-beta: a case report. J Hum Hypertens 28:340–1
Gosse P, Coulon P, Papaioannou G, et al (2011) Impact of malignant arterial hypertension on the heart. J Hypertens 29:798–802
Wong TY, Mitchell P (2004) Hypertensive retinopathy. N Engl J Med 351:2310–7
Van den Born BJ, Honnebier UP, Koopmans RP, van Montfrans GA (2005) Microangiopathic hemolysis and renal failure in malignant hypertension. Hypertension 45:246–51
Lane DA, Lip GY, Beevers DG (2009) Improving survival of malignant hypertension patients over 40 years. Am J Hypertens 22:1199–204
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rubin, S., Gosse, P., Gruson, D. et al. Diagnostic et traitement de l’hypertension artérielle maligne en réanimation. Réponse aux auteurs. Réanimation 24, 615–617 (2015). https://doi.org/10.1007/s13546-015-1093-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13546-015-1093-z